Grant: Project Grant
McMaster University
$180,000.00
A randomized controlled trial of anterior-posterior versus anterior-lateral shock vectors for electrical cardioversion of atrial fibrillation (SHOCK-VECTOR)
FY 2024-25
Summary
Atrial fibrillation (AF) is the most common heart rhythm disorder, causing rapid and irregular heartbeats. Symptoms include shortness of breath and chest discomfort, which can lead to serious issues like strokes, heart failure and death. AF is linked to over half a million deaths globally, costing billions in healthcare, especially in North America.
A primary early treatment for AF is electrical cardioversion, where an electrical shock resets the heart's rhythm. This method is safe, affordable, and widely available, but there's no standardized way to perform cardioversion. Our research examines whether placing patches on the chest in an anterolateral (front-to-side) position is more effective than the anteroposterior (front-to-back) position. We are also investigating if applying manual pressure on the patches improves results.
We are conducting a randomized controlled study to compare the two patch positions and the effect of manual pressure. Patients will be randomly assigned to receive either patch position and, if necessary, will also be randomized to receive manual pressure during a second shock.
Our study has enrolled over 400 participants so far, and we are looking to expand to include more diverse patients across different hospitals. Funding from CIHR would help us continue our research and include more patients from across Canada.
Our study is safe, simple and cost-effective. Improving cardioversion techniques could lead to better outcomes for AF patients, potentially reducing hospital visits and complications and boosting the efficacy of complex treatments like ablation. If our findings confirm that the patch position or manual pressure improves cardioversion, it could change patient care for more than 40 million patients worldwide with AF.
Department
Program
Project Grant
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
523249
Name
McIntyre William F
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Clinical Investigation - D: Cardiovascular Systems
Projecttitle
A randomized controlled trial of anterior-posterior versus anterior-lateral shock vectors for electrical cardioversion of atrial fibrillation (SHOCK-VECTOR)
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$180,000
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Atrial Fibrillation; Cardioversion; Electrodes; Intervention; Manual Pressure; Sinus Rhythm
Abstract
Atrial fibrillation (AF) is the most common heart rhythm disorder, causing rapid and irregular heartbeats. Symptoms include shortness of breath and chest discomfort, which can lead to serious issues like strokes, heart failure and death. AF is linked to over half a million deaths globally, costing billions in healthcare, especially in North America.
A primary early treatment for AF is electrical cardioversion, where an electrical shock resets the heart's rhythm. This method is safe, affordable, and widely available, but there's no standardized way to perform cardioversion. Our research examines whether placing patches on the chest in an anterolateral (front-to-side) position is more effective than the anteroposterior (front-to-back) position. We are also investigating if applying manual pressure on the patches improves results.
We are conducting a randomized controlled study to compare the two patch positions and the effect of manual pressure. Patients will be randomly assigned to receive either patch position and, if necessary, will also be randomized to receive manual pressure during a second shock.
Our study has enrolled over 400 participants so far, and we are looking to expand to include more diverse patients across different hospitals. Funding from CIHR would help us continue our research and include more patients from across Canada.
Our study is safe, simple and cost-effective. Improving cardioversion techniques could lead to better outcomes for AF patients, potentially reducing hospital visits and complications and boosting the efficacy of complex treatments like ablation. If our findings confirm that the patch position or manual pressure improves cardioversion, it could change patient care for more than 40 million patients worldwide with AF.
Competitiondate
202503
Approvedterm2
3 yrs 0 mth
Pinamesdelim
McIntyre, William F
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $180,000~ $0~